Issue 8/2016
Content (9 Articles)
Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels
James S. Yeh, Ameet Sarpatwari, Aaron S. Kesselheim
Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease
Alexander C. Fanaroff, Matthew T. Roe
Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease
Rolf Teschke, Gaby Danan
Age at First Rotavirus Vaccination and Risk of Intussusception in Infants: A Public Health Modeling Analysis
Chee Fu Yung, Chia Yin Chong, Koh Cheng Thoon
Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study
Elizabeth X. Zheng, Simona Rossi, Robert J. Fontana, Raj Vuppalanchi, Jay H. Hoofnagle, Ikhlas Khan, Victor J. Navarro
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Megan E. B. Clowse, Steven R. Feldman, John D. Isaacs, Alexandra B. Kimball, Vibeke Strand, Richard B. Warren, Daniel Xibillé, Yan Chen, Donald Frazier, Jamie Geier, James Proulx, Amy Marren
Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment
Mulugeta Russom, Dawit Tesfai, Semere Gebregiorgis, Abdulmumini Usman, Selam Mihreteab, Iyassu Bahta, Elsa Mekonnen, Selamawit Ghebrehiwet, Gelila Abrham
The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
Leàn Rolfes, Florence van Hunsel, Katja Taxis, Eugène van Puijenbroek
Is Earlier Signal Detection Always Better?
Alan M. Hochberg, Stella Stergiopoulos